The FDA gave Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge the ...

Big Island health professionals are concerned changes to U.S. Food and Drug Administration rules for COVID-19 vaccines could ...

BofA analyst Alec Stranahan reiterated a Hold rating on Novavax, Inc. (NASDAQ:NVAX) stock, setting a price target of $10. The approval of Nuvaxovid for use in older and high-risk adults will generate ...